Biotech reporter for @business. Views are my own. Tips: gsmith233@bloomberg.net
Joined August 2008
- Tweets 923
- Following 1,223
- Followers 8,703
- Likes 12,654
16 Photos and videos
Pinned Tweet
7 Jul 2025
Parents are getting their kids vaccinated early, worried that recent moves by RFK Jr could limit access to childhood shots. bloomberg.com/news/articles/…
7
3
30
30,289
Gerry Smith retweeted
Jun 10
This Parking Spot Is Free. Should It Be? with @stefanoschen and @edenweingart: nytimes.com/interactive/2026…
8
7
22
3,622
May 27
Scoop: Blackstone is providing as much as $1.3 billion to Apogee to help the biotech company advance a potential competitor to Dupixent
bloomberg.com/news/articles/…
2
1,984
Gerry Smith retweeted
May 21
In one of the first moves of the post-Makary era, FDA has scheduled a meeting of outside experts to discuss Moderna's controversial mRNA flu vaccine application. w/ @gerryfsmith bloomberg.com/news/articles/…
2
7
21
6,240
May 20
New: US officials are working with a small biotech company, Mapp Biopharmaceutical, to provide an experimental treatment that may be used in patients exposed to Ebola. google.com/url?q=bloomberg.c…
1
3
474
May 18
New: Can AI Drug Development Live Up to the Hype?
The industry is pouring billions into the idea that it can make the process faster and more predictable, but there's reason for caution:
bloomberg.com/news/articles/…
3
10
12,522
Gerry Smith retweeted
May 15
More turnover at FDA: The agency is replacing the head of its vaccine and gene therapy division with FDA adviser Karim Mikhail, while current acting director Katherine Szarama will stay at the agency. Other changes here:
bloomberg.com/news/articles/…
May 15
New: FDA's top drug regulator Tracy Beth Høeg is departing the agency following Marty Makary's exit earlier this week. CDER deputy director Mike Davis will serve as acting director bloomberg.com/news/articles/…
3
10
19
7,944
May 12
Marty Makary’s exit as head of the FDA is giving the biotech industry hope for stability after months of turmoil.
"It’s been a circus," one analyst said, adding that he's looking forward to "a new leader and less drama."
bloomberg.com/news/articles/…
1
12
30
6,218
Gerry Smith retweeted
President Donald Trump plans to oust FDA Commissioner Marty Makary following tumult at the agency (confirming @l_e_whyte)
🎁: bloomberg.com/news/articles/…
6
10
43
5,880
May 7
Scoop: Blackstone is investing $250 million in the biotech startup Anagram Therapeutics, part of the private equity giant’s strategy to own more cutting-edge drugmakers.
bloomberg.com/news/articles/…
1
821
Gerry Smith retweeted
A true team effort to illuminate management issues at FDA with @jessicanix_ @gerryfsmith @rileyraygriffin @g0ingmad @RobertLangreth @annaedney
🎁: bloomberg.com/news/features/…
Marty Makary was supposed to be one of President Donald Trump’s more conventional advisers. Instead, tension and controversy have clouded his tenure. Insiders say one more high-profile misstep could put the FDA commissioner’s job at risk. bloomberg.com/news/features/…
3
11
44
6,497
Gerry Smith retweeted
ICYMI our story with Upshot about the debate over raising income taxes for wealthy New Yorkers: nytimes.com/2026/05/02/upsho…
5
6
1,563
Marty Makary was supposed to be one of President Donald Trump’s more conventional advisers. Instead, tension and controversy have clouded his tenure. Insiders say one more high-profile misstep could put the FDA commissioner’s job at risk. bloomberg.com/news/features/…
28
52
143
44,507
Gerry Smith retweeted
May 1
NEW: Dylan Field Turner had cycled through antidepressants for a decade before trying Spravato. “It shakes things loose,” he said. “It’s like changing your spark plugs.”
More here on J&J’s blockbuster depression treatment for @business bloomberg.com/features/2026-…
2
21
7,170
Gerry Smith retweeted
Bristol Myers paid $14 billion for a neuroscience drug with the potential to transform the treatment of schizophrenia, an overlooked area of mental health care. It’s not working out bloomberg.com/news/features/…
1
1
437
Gerry Smith retweeted
Novartis, Amgen and Eli Lilly are all betting that slashing levels of a particularly bad form of cholesterol called Lp(a) will cut a person's risk of heart attack and create the next blockbuster drugs for heart disease
cnbc.com/2026/04/27/lpa-drug…
1
3
20
5,011
Apr 28
New: When Cobenfy was approved more than 18 months ago, it was celebrated as a game-changer for the 23 million people worldwide with schizophrenia. But after more than a full year on the market, it has struggled to gain traction. bloomberg.com/news/features/…
4
4
4
15,862
Apr 24
Scoop: Mark Cuban’s low-cost online pharmacy will sell the blockbuster blood thinner Eliquis starting next week, a win for the billionaire’s effort to transform the way drugs are sold in the US. bloomberg.com/news/articles/…
2
198
Apr 23
NEW: Regeneron will offer a gene therapy that restored hearing for a small number of profoundly deaf children at no cost after US regulators approved the treatment. bloomberg.com/news/articles/…
2
13
29
18,414
Apr 23
The mother of a child who got the treatment told me: “I can tell him how much I love him and he hears me. It’s such a different world.”
1
261
Gerry Smith retweeted
Trump's Plan to Cut US Drug Prices Backfires for Europe
Who could have predicted? Rather than endanger their US profits, some drugmakers withhold new medicines from European markets. 🎁from @gerryfsmith @ashleighfurlong and @fabiennekatrin bloomberg.com/news/features/…
3
2
462